S&P 500   4,586.18 (-1.48%)
DOW   34,600.29 (-1.52%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,586.18 (-1.48%)
DOW   34,600.29 (-1.52%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,586.18 (-1.48%)
DOW   34,600.29 (-1.52%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,586.18 (-1.48%)
DOW   34,600.29 (-1.52%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
NASDAQ:QLGN

Qualigen Therapeutics Institutional Ownership

$1.45
-0.13 (-8.23%)
(As of 11/30/2021 01:31 PM ET)
Add
Compare
Today's Range
$1.34
$1.65
50-Day Range
$0.94
$2.56
52-Week Range
$0.93
$4.66
Volume
216,010 shs
Average Volume
2.47 million shs
Market Capitalization
$42.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.6

Institutional Ownership Changes (13F Filings) for Qualigen Therapeutics (NASDAQ:QLGN)

Current
Institutional Ownership
Percentage
8.66%

Number of
Institutional Buyers
(last 12 months)
21

Total
Institutional Inflows
(last 12 months)
$4.17 M

Number of
Institutional Sellers
(last 12 months)
1

Total
Institutional Outflows
(last 12 months)
$52.80 K

Skip Chart & View Institutional Buying and Selling Data

Institutional Buying and Selling by Quarter


Qualigen Therapeutics (NASDAQ QLGN) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2021Franklin Resources Inc.82,000$0.11M0.0%N/A0.283%
11/15/2021GSA Capital Partners LLP78,687$0.10M0.0%N/A0.271%
11/12/2021Geode Capital Management LLC221,146$0.29M0.0%+31.1%0.763%
10/14/2021Hatton Consulting Inc.27,195$35K0.0%-26.9%0.094%
8/16/2021State Street Corp104,314$0.21M0.0%N/A0.362%
8/13/2021Renaissance Technologies LLC113,911$0.23M0.0%N/A0.395%
8/13/2021Geode Capital Management LLC168,702$0.34M0.0%+10.3%0.585%
8/13/2021Vanguard Group Inc.1,023,911$2.04M0.0%+239.9%3.551%
8/11/2021Commonwealth Equity Services LLC137,510$0.27M0.0%+10.9%0.477%
8/2/2021Hatton Consulting Inc.37,195$74K0.1%-35.0%0.129%
6/23/2021StoneX Group Inc.13,442$36K0.0%N/A0.047%
5/17/2021Price T Rowe Associates Inc. MD107,500$0.29M0.0%N/A0.373%
5/12/2021Geode Capital Management LLC152,898$0.41M0.0%+24.3%0.530%
5/11/2021Vontobel Holding Ltd.25,300$68K0.0%N/A0.088%
5/10/2021GSA Capital Partners LLP18,031$49K0.0%N/A0.063%
5/5/2021Hatton Consulting Inc.57,195$0.15M0.1%N/A0.198%
5/4/2021Commonwealth Equity Services LLC124,049$0.33M0.0%+716.3%0.538%
4/28/2021Perkins Capital Management Inc.31,652$85K0.0%N/A0.137%
4/22/2021HighMark Wealth Management LLC80,094$0.22M0.2%N/A0.347%
2/17/2021Cetera Investment Advisers40,275$0.12M0.0%+140.2%0.175%
2/11/2021Northern Trust Corp38,731$0.12M0.0%N/A0.168%
2/10/2021QS Investors LLC82,000$0.25M0.0%N/A0.356%
2/9/2021Wells Fargo & Company MN30,577$92K0.0%+19,010.6%0.133%
2/9/2021Bank of New York Mellon Corp20,824$63K0.0%N/A0.090%
2/5/2021BlackRock Inc.317,818$0.96M0.0%+1.2%1.378%
2/5/2021US Bancorp DE9,851$29K0.0%N/A0.043%
1/27/2021CRA Financial Services LLC19,957$60K0.0%N/A0.087%
11/13/2020Cetera Investment Advisers16,765$83K0.0%N/A0.080%
11/12/2020JPMorgan Chase & Co.5,600$27K0.0%N/A0.027%
11/6/2020BlackRock Inc.314,126$1.56M0.0%+54,247.1%1.494%
8/17/2020Jane Street Group LLC10,783$43K0.0%N/A0.056%
8/7/2020Virtu Financial LLC29,887$0.12M0.0%N/A0.155%
(Data available from 1/1/2016 forward)













Qualigen Therapeutics (NASDAQ:QLGN) Institutional Ownership Frequently Asked Questions

Who are the institutional owners of Qualigen Therapeutics?

During the previous two years, 24 institutional investors and hedge funds held shares of Qualigen Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($2.04M), BlackRock Inc. ($0.96M), Price T Rowe Associates Inc. MD ($0.29M), Geode Capital Management LLC ($0.29M), Commonwealth Equity Services LLC ($0.27M), QS Investors LLC ($0.25M), and Renaissance Technologies LLC ($0.23M).Learn more on QLGN's institutional investors

What percentage of Qualigen Therapeutics stock is owned by institutional investors?

8.66% of Qualigen Therapeutics stock is owned by institutional investors. Learn more on QLGN's institutional investor holdings

Which institutional investors have been buying Qualigen Therapeutics stock?

Of the 24 institutional investors that purchased Qualigen Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($0.72M), BlackRock Inc. ($0.32M), Commonwealth Equity Services LLC ($0.12M), Renaissance Technologies LLC ($0.11M), Price T Rowe Associates Inc. MD ($0.11M), State Street Corp ($0.10M), and Geode Capital Management LLC ($98.11K).

How much institutional buying is happening at Qualigen Therapeutics?

Institutional investors have bought a total of 2,260,831 shares in the last 24 months. This purchase volume represents approximately $5.83M in transactions.

Which Qualigen Therapeutics institutionals have been selling company stock?

The following institutional investors have sold Qualigen Therapeutics stock in the last 24 months: Hatton Consulting Inc. ($30K).

How much institutional selling is happening at Qualigen Therapeutics?

Institutional investors have sold a total of 30,000 shares in the last 24 months. This volume of shares sold represents approximately $52.80K in transactions.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.